Inhibition of indoleamine 2,3-dioxygenase 1 synergizes with oxaliplatin for efficient colorectal cancer therapy
2021 · Molecular Therapy — Methods & Clinical Development · 6 citations
https://doi.org/10.1016/j.omtm.2020.12.013
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
498
Citations
10
h-index
11
i10-index
Longchang Huang is an academic researcher from Nanjing General Hospital of Nanjing Military Command. The author has contributed to research in topics: MicroRNA in disease regulation & Nutrition and Health in Aging & Cancer-related molecular mechanisms research. The author has an h-index of 10, co-authored 17 publications.
ORCID: 0000-0001-9136-8625https://doi.org/10.1016/j.omtm.2020.12.013
https://doi.org/10.1038/s41598-024-78783-8
Click to start Chat